These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 7562759)

  • 1. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
    Clements P; Lachenbruch P; Siebold J; White B; Weiner S; Martin R; Weinstein A; Weisman M; Mayes M; Collier D
    J Rheumatol; 1995 Jul; 22(7):1281-5. PubMed ID: 7562759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.
    Clements PJ; Lachenbruch PA; Seibold JR; Zee B; Steen VD; Brennan P; Silman AJ; Allegar N; Varga J; Massa M
    J Rheumatol; 1993 Nov; 20(11):1892-6. PubMed ID: 8308774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of skin scores and clinical measurements in scleroderma.
    Pope JE; Baron M; Bellamy N; Campbell J; Carette S; Chalmers I; Dales P; Hanly J; Kaminska EA; Lee P
    J Rheumatol; 1995 Jul; 22(7):1271-6. PubMed ID: 7562757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.
    Silman A; Harrison M; Brennan P
    J Rheumatol; 1995 Jul; 22(7):1277-80. PubMed ID: 7562758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
    Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
    J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis.
    Czirják L; Nagy Z; Aringer M; Riemekasten G; Matucci-Cerinic M; Furst DE;
    Ann Rheum Dis; 2007 Jul; 66(7):966-9. PubMed ID: 17234649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis.
    Nagy Z; Bálint Z; Farkas H; Radics J; Kumánovics G; Minier T; Varjú C; Czirják L
    Rheumatology (Oxford); 2009 Mar; 48(3):309-14. PubMed ID: 19181657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score.
    Foeldvari I; Wierk A
    Rheumatology (Oxford); 2006 Jan; 45(1):76-8. PubMed ID: 16174648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis.
    Moore TL; Lunt M; McManus B; Anderson ME; Herrick AL
    Rheumatology (Oxford); 2003 Dec; 42(12):1559-63. PubMed ID: 12867579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis.
    Kaloudi O; Bandinelli F; Filippucci E; Conforti ML; Miniati I; Guiducci S; Porta F; Candelieri A; Conforti D; Grassiri G; Grassi W; Matucci-Cerinic M
    Ann Rheum Dis; 2010 Jun; 69(6):1140-3. PubMed ID: 19762365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure.
    Kuwahara Y; Shima Y; Shirayama D; Kawai M; Hagihara K; Hirano T; Arimitsu J; Ogata A; Tanaka T; Kawase I
    Rheumatology (Oxford); 2008 Jul; 47(7):1018-24. PubMed ID: 18440998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ; Hurwitz EL; Wong WK; Seibold JR; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Furst DE
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.